 BOSTON, Feb. 03, 2022 GLOBE NEWSWIRE -- AVEO Oncology Nasdaq: AVEO, a commercial stage, oncology-focused biopharmaceutical company, today announced that members of its senior management team will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 9:20 a.m. eastern time. 